The 67th American Society of Hematology (ASH) Annual Meeting will be held in Orlando, Florida, USA, from December 6 to 9, 2025. Three studies from the Department of Hematology of…

From December 6–9, 2025, the 67th American Society of Hematology (ASH) Annual Meeting was held in Orlando, bringing together hematology experts worldwide to share cutting-edge research and major clinical breakthroughs.…

At present, the treatment of myelofibrosis (MF) continues to face significant challenges. A proportion of patients are intolerant of or develop resistance to existing JAK inhibitors, leaving limited subsequent therapeutic…

For patients with relapsed/refractory (R/R) T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma (T-ALL/LBL), current treatment options remain limited and outcomes are unsatisfactory, posing major clinical challenges. At the Annual Meeting of the…

The 67th Annual Meeting of the American Society of Hematology (ASH) was held in Orlando from December 6 to 9, 2025. As the world’s largest and most influential hematology conference,…

Allogeneic hematopoietic cell transplantation (allo-HCT) remains the only curative option for patients with myelodysplastic syndromes (MDS). However, clinical decision-making in the transplant setting remains challenging. Two critical and unresolved issues…

The 2025 Annual Meeting of the American Society of Hematology (ASH) was held in Orlando from December 6 to 9. As one of the world’s premier events in hematology, the…

CAR-T cell therapy has achieved transformative success in lymphoid malignancies, yet its application in acute myeloid leukemia (AML) remains highly challenging. Against this backdrop, a sequential strategy integrating CD7-targeted CAR-T…

At a recent Annual Meeting of the American Society of Hematology (ASH), a prospective study conducted by Prof. Yi Luo’s team at The First Affiliated Hospital, Zhejiang University School of…

December 6–9, 2025, the 67th Annual Meeting of the American Society of Hematology (ASH) was held in Orlando, USA. As the world’s largest and most influential hematology conference, ASH annually…